切换至 "中华医学电子期刊资源库"

中华普通外科学文献(电子版) ›› 2020, Vol. 14 ›› Issue (04) : 241 -244. doi: 10.3877/cma.j.issn.1674-0793.2020.04.001

所属专题: 文献

专家论坛

免疫营养素临床应用的现状与争议
陈国庆1, 杨桦1   
  1. 1. 400037 重庆,陆军军医大学新桥医院普通外科
  • 收稿日期:2020-07-16 出版日期:2020-08-01
  • 基金资助:
    国家教育部创新团队项目(IRT_17R16)

Clinical application status and controversy of immunonutrients

Guoqing Chen1, Hua Yang1   

  • Received:2020-07-16 Published:2020-08-01
引用本文:

陈国庆, 杨桦. 免疫营养素临床应用的现状与争议[J]. 中华普通外科学文献(电子版), 2020, 14(04): 241-244.

Guoqing Chen, Hua Yang. Clinical application status and controversy of immunonutrients[J]. Chinese Archives of General Surgery(Electronic Edition), 2020, 14(04): 241-244.

[1]
Pierre JF, Heneghan AF, Lawson CM, et al. Pharmaconutrition review: physiological mechanisms[J]. JPEN J Parenter Enteral Nutr, 2013, 37(5 Suppl): 51S-65S.
[2]
Kristine Koekkoek W, Panteleon V, van Zanten AR. Current evidence on ω-3 fatty acids in enteral nutrition in the critically ill: A systematic review and Meta-analysis[J]. Nutrition, 2019, 59: 56-68.
[3]
Palmer AJ, Ho CK, Ajibola O, et al. The role of ω-3 fatty acid supplemented parenteral nutrition in critical illness in adults: A systematic review and Meta-analysis[J]. Crit Care Med, 2013, 41(1): 307-316.
[4]
Manzanares W, Dhaliwal R, Jurewitsch B, et al. Alternative lipid emulsions in the critically ill: A systematic review of the evidence[J]. Intensive Care Med, 2013, 39(10): 1683-1694.
[5]
Zhu D, Zhang Y, Li S, et al. Enteral omega-3 fatty acid supplementation in adult patients with acute respiratory distress syndrome: A systematic review of randomized controller trials with Meta-analysis and trial sequential analysis[J]. Intensive Care Med, 2014, 40(4): 504-512.
[6]
Singer P, Blaser AR, Berger MM, et al. ESPEN guideline on clinical nutrition in the intensive care unit[J]. Clin Nutr, 2019, 38(1): 48-79.
[7]
Pradelli L, Mayer K, Muscaritoli M, et al. n-3 fatty acid-enriched parenteral nutrition regimens in elective surgical and ICU patients: AMeta-analysis[J]. Crit Care, 2012, 16(5): R184.
[8]
Li NN, Zhou Y, Qin XP, et al. Does intravenous fish oil benefit patients post-surgery? A Meta-analysis of randomised controlled trials[J]. Clin Nutr, 2014, 33(2): 226-239.
[9]
Weimann A, Braga M, Carli F, et al. ESPEN guideline: clinical nutrition in surgery[J]. Clin Nutr, 2017, 36(3): 623-650.
[10]
Ruiz-León AM, Lapuente M, Estruch R, et al. Clinical advances in immunonutrition and atherosclerosis: A review[J]. Front Immunol, 2019, 10: 837.
[11]
Su KP, Tseng PT, Lin PY, et al. Association of use of Omega-3 polyunsaturated fatty acids with changes in severity of anxiety symptoms: A systematic review and Meta-analysis[J]. JAMA Netw Open, 2018, 1(5): e182327.
[12]
Meyer BJ, Groot R. Effects of omega-3 long chain polyunsaturated fatty acid supplementation on cardiovascular mortality: the importance of the dose of DHA[J]. Nutrients, 2017, 9(12): 1305.
[13]
Hidayat K, Yang J, Zhang Z, et al. Effect of omega-3 long-chain polyunsaturated fatty acid supplementation on heart rate: A Meta-analysis of randomized controlled trials[J]. Eur J Clin Nutr, 2018, 72(6): 805-817.
[14]
Cawood AL, Ding R, Napper FL, et al. Eicosapentaenoic acid (EPA) from highly concentrated n-3 fatty acid ethyl esters is incorporated into advanced atherosclerotic plaques and higher plaque EPA is associated with decreased plaque inflammation and increased stability[J]. Atherosclerosis, 2010, 212(1): 252-259.
[15]
Raygan F, Taghizadeh M, Mirhosseini N, et al. A comparison between the effects of flaxseed oil and fish oil supplementation on cardiovascular health in type 2 diabetic patients with coronary heart disease: A randomized, double-blinded, placebo-controlled trial[J]. Phytother Res, 2019, 33(7): 1943-1951.
[16]
O'Mahoney LL, Matu J, Price OJ, et al. Omega-3 polyunsaturated fatty acids favourably modulate cardiometabolic biomarkers in type 2 diabetes: A Meta-analysis and Meta-regression of randomized controlled trials[J]. Cardiovasc Diabetol, 2018, 17(1): 98.
[17]
Nose K, Yang H, Sun X, et al. Glutamine prevents total parenteral nutrition-associated changes to intraepithelial lymphocyte phenotype and function: A potential mechanism for the preservation of epithelial barrier function[J]. J Interferon Cytokine Res, 2010, 30(2): 67-80.
[18]
Chen QH, Yang Y, He HL, et al. The effect of glutamine therapy on outcomes in critically ill patients: AMeta-analysis of randomized controlled trials[J]. Crit Care, 2014, 18(1): R8.
[19]
Heyland D, Muscedere J, Wischmeyer PE, et al. A randomized trial of glutamine and antioxidants in critically ill patients[J]. N Engl J Med, 2013, 368(16): 1489-1497.
[20]
Heyland DK, Elke G, Cook D, et al. Glutamine and antioxidants in the critically ill patient: A post hoc analysis of a large-scale randomized trial[J]. JPEN J Parenter Enteral Nutr, 2015, 39(4): 401-409.
[21]
Wernerman J. How to understand the results of studies of glutamine supplementation[J]. Crit Care, 2015, 19: 385.
[22]
Cruzat V, Macedo Rogero M, Noel Keane K, et al. Glutamine: metabolism and immune function, supplementation and clinical translation[J]. Nutrients, 2018, 10(11): E1564.
[23]
Tjäder I, Rooyackers O, Forsberg AM, et al. Effects on skeletal muscle of intravenous glutamine supplementation to ICU patients[J]. Intensive Care Med, 2004, 30(2): 266-275.
[24]
Singer P, Berger MM, Van den Berghe G, et al. ESPEN Guidelines on Parenteral Nutrition: intensive care[J]. Clin Nutr, 2009, 28(4): 387-400.
[25]
Harvey SE, Parrott F, Harrison DA, et al. Trial of the route of early nutritional support in critically ill adults[J]. N Engl J Med, 2014, 371(18): 1673-1684.
[26]
Heyland DK, Novak F. Immunonutrition in the critically ill patient: more harm than good?[J]. JPEN J Parenter Enteral Nutr, 2001, 25(2 Suppl): S51-S55.
[27]
Bertolini G, Iapichino G, Radrizzani D, et al. Early enteral immunonutrition in patients with severe sepsis: results of an interim analysis of a randomized multicentre clinical trial[J]. Intensive Care Med, 2003, 29(5): 834-840.
[28]
Drover JW, Dhaliwal R, Weitzel L, et al. Perioperative use of arginine-supplemented diets: A systematic review of the evidence[J]. J Am Coll Surg, 2011, 212(3): 385-399, 399.e1.
[29]
Vidal-Casariego A, Calleja-Fernández A, Villar-Taibo R, et al. Efficacy of arginine-enriched enteral formulas in the reduction of surgical complications in head and neck cancer: A systematic review and meta-analysis[J]. Clin Nutr, 2014, 33(6): 951-957.
[30]
Badurdeen S, Mulongo M, Berkley JA. Arginine depletion increases susceptibility to serious infections in preterm newborns[J]. Pediatr Res, 2015, 77(2): 290-297.
[31]
McClave SA, Taylor BE, Martindale RG, et al. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: society of critical care medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) [J]. J Parenter Enteral Nutr, 2016, 40(2): 159-211.
[32]
McClave SA, DiBaise JK, Mullin GE, et al. ACG clinical guideline: nutrition therapy in the adult hospitalized patient[J]. Am J Gastroenterol, 2016, 111(3): 315-335.
No related articles found!
阅读次数
全文


摘要